Literature DB >> 32242620

Nrf-2: The Target of Vascular Dysfunction in Diabetes.

Eisuke Amiya1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32242620     DOI: 10.1093/ajh/hpaa052

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


× No keyword cloud information.
  2 in total

Review 1.  Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Madalina Ioana Anton; Mariana Floria; Petronela Nicoleta Seritean Isac; Loredana Liliana Hurjui; Claudia Cristina Tarniceriu; Claudia Florida Costea; Manuela Ciocoiu; Ciprian Rezus
Journal:  Biomolecules       Date:  2022-09-02

2.  Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses.

Authors:  Xiaowen Shi; Bin Zhang; Zhenliang Chu; Bingjiang Han; Xueping Zhang; Ping Huang; Jibo Han
Journal:  Cardiovasc Ther       Date:  2021-07-01       Impact factor: 3.023

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.